HANNAH ENGLISH: Open Payments
NPI 1528711256 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 106 payments from 18 companies in 2025. Trend: 2023 $358 · 2024 $1,424 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $456 |
| Otsuka America Pharmaceutical, Inc. | 11 | $267 |
| Novo Nordisk Inc | 7 | $259 |
| Corium, LLC | 16 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $136 |
| Amgen Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $57 |
| Tris Pharma Inc | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
Products named: REXULTI, VRAYLAR, Azstarys, QULIPTA, CAPLYTA, Ozempic, Wegovy, UBRELVY.
Industry payments across KY — which companies pay providers there.
